Document is current
Any future updates will be listed below
-
Authors
Andrew, Cole O.
Bernard, Omolo
Tim, Chege
Isabella, Ochola-Oyier L.
John, Magudha
Sam, Kinyanjui
Magdalene, Ongas
Ishmael, Abbas
Boniface, Onyango O.
Regina, Kandie
Keitany, Kibor
Gilbert, Kokwaro
-
Funding
Funding for this research was provided by:
Medicines for Malaria Venture (PO20/00538)
- License Information
-
More Information
Article History
Received: 17 December 2025
Accepted: 28 March 2026
First Online: 10 April 2026
Declarations
:
: The authors declare no competing interests.
: Written informed consent was obtained from all participants included in the study. For participants under 18 years of age, written informed consent was obtained from the parents or legal guardians. All participants were informed of the study objectives, procedures, potential risks and benefits, and their rights not to participate in this study without any effect on their care. The consent process was conducted in English, Kiswahili, and Dholuo languages as preferred by the participants and all questions were answered before participation commenced.
